Sitagliptin is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used in conjunction with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus[FDA label,A2260,A2255,A2256]. The effect of this medication leads to glucose dependent increases in insulin and decreases in glucagon to improve control of blood sugar[FDA label,A2255]. Sitagliptin was granted FDA approval on October 16, 2006[L6061].
Synonyms
Sitagliptin hydrochloride monohydrate
Sitagliptin malate
Sitagliptina
Sitagliptinum
Sitagliptin phosphate
Sitagliptine
Sitagliptin tartrate hemihydrate
Sitagliptin
Sitagliptin fumarate
Brand Names
Nat-sitagliptin
Januvia
Zituvio
Pro-sitagliptin
PMS-sitagliptin Tartrate/metformin
Sandoz Sitagliptin-metformin XR
Sitagliptin Phosphate/Metformin Hydrochloride
Ag-sitagliptin
Jamp Sitagliptin
Apo-sitagliptin-metformin
Ristfor
Sitagliptin Sun
Taro-sitagliptin Fumarate
Juvisync
Ach-sitagliptin
Janumet XR
Teva-sitagliptin Malate / Metformin
Apo-sitagliptin
Steglujan
Sandoz Sitagliptin
Sitagliptin
Tesavel
PMS-sitagliptin-metformin
Riva Sitagliptin
Riva-sitagliptin Tartrate/metformin
Apo-sitagliptin/metformin XR
Prz-sitagliptin
Sandoz Sitagliptin-metformin
Reddy-sitagliptin and Metformin Hydrochloride
Reddy-sitagliptin
Sitagliptin/metformin Hydrochloride Sun
Bio-sitagliptin
Velmetia
Auro-sitagliptin Hydrochloride and Metformin Hydrochloride
M-sitagliptin
Apo-sitagliptin Malate / Metformin Hydrochloride
Pro-sitagliptin Malate
Prz-sitagliptin-metformin
Riva Sitagliptin/metformin
Sitagliptin Accord
Teva-sitagliptin Malate
PMS-sitagliptin
Sitagliptin and metformin hydrochloride
Zituvimet
Sitagliptin - Metformin
Janumet
Sitagliptin and Metformin Hydrochloride
Pro-sitagliptin-metformin
Nra-sitagliptin
Sitagliptin-metformin
Sitagliptin/metformin Hydrochloride Accord
Auro-sitagliptin
Xelevia
Efficib
Pro-sitagliptin Malate / Metformin Hydrochloride
Ristaben
Apo-sitagliptin Malate
Zituvimet XR
Indication
Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is not used to treat type 1 diabetes or patients with a history of pancreatitis.[L41220] It is also used in combination with [metformin] [L41215] or [ertugliflozin].[L41225]
Categories
Agents causing angioedema
Alimentary Tract and Metabolism
Blood Glucose Lowering Agents
Cytochrome P-450 CYP2C8 Substrates
Cytochrome P-450 CYP3A Substrates
Cytochrome P-450 CYP3A4 Substrates
Cytochrome P-450 Substrates
DPP-IV Inhibitors
Drugs that are Mainly Renally Excreted
Drugs Used in Diabetes
Enzyme Inhibitors
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682